A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Clinical trial NCT06602479 · RECRUITING
Trial details
- NCT number
- NCT06602479
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-07
- Primary completion
- 2026-12-18
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.